ReNeuron Group plc (RNUGF)

[georgejjl]

By or before Friday April 26, 2019 NEWS!!! regarding (RNUGF) ReNeuron Group plc

“The business remains significantly undervalued, and we look forward to further clinical data on the retinal programme at the end of April, and potential further licensing activity, as near-term catalysts to build on recent momentum,” it said in a note earlier this month.

https://www.proactiveinvestors.co.uk/companies/news/218786/ReNeuron-primed-for-further-progress--218786.html

Further read-outs from the patients treated in the Phase 1/2 study will be presented at the 6th Annual Retinal Cell and Gene Therapy Innovation Summit, taking place in Vancouver, Canada, on 26 April 2019. Information regarding this conference may be found at:

https://www.regonline.com/builder/site/default.aspx?EventID=2548135

The Company will make a further announcement later this month, when these further read-outs from the study are known.

The Company’s RP clinical programme benefits from Orphan Drug Designation in both Europe and the US, as well as Fast Track designation from the FDA.

Olav Hellebø, Chief Executive Officer of ReNeuron, said:
“We remain greatly encouraged by the continued positive efficacy we are seeing in the ongoing Phase 1/2 study with our hRPC cell therapy candidate for retinitis pigmentosa. We look forward to providing a further update on progress with the study at the time of the Innovation Summit in Vancouver later this month.”

http://4965zs3ha2l125fk78zkozo3.wpengine.netdna-cdn.com/wp-content/uploads/RENE-RP-clinical-update-FINAL.pdf

Good luck and GOD bless,

George